Clinical Trials Directory

Trials / Completed

CompletedNCT01450371

Interferential Electrical Stimulation and Vasodilatation in Healthy Individuals

Interferential Electrical Stimulation Improves Peripheral Vasodilatation in Healthy Individuals: A Randomized Crossover Study

Status
Completed
Phase
Study type
Observational
Enrollment
11 (actual)
Sponsor
Hospital de Clinicas de Porto Alegre · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Interferential electrical stimulation (IES) increases local blood flow. It is not known whether increases in blood flow may be caused by inhibition of sympathetic activity, mediated by muscle metaboreflex activity. The purpose of this study was to evaluate the effect of IES on metaboreflex activation in healthy subjects.

Detailed description

The study sample consisted of 11 healthy young individuals. All subjects were non-smokers, non-obese and free of any signs or symptoms of disease, as revealed by medical history, physical examination and electrocardiogram at rest and during cardiopulmonary exercise testing. Exclusion criteria were pregnancy, breast-feeding, alcohol or drug abuse, and any medication with potential effects on cardiovascular variables. Subjects were asked not to drink caffeine-containing drinks or exercise for at least 12 and 48 hours, respectively, before the experimental protocols.

Conditions

Interventions

TypeNameDescription
DEVICEInterferentialThe individuals are treated acutely with IES during 30 min, providing a continuous flow of symmetrical rectangular interferential current biphasic pulses using bipolar electrodes with two channels and a slope of 1/5/1. The fixed current is adjusted to 4000 Hz, with the current AMF at 100 Hz and an AMF variation of 25 Hz (25% of AMF).
DEVICEInterferential PlaceboThe same instructions and electrode positions were provided to the placebo, although the equipment did not provide any stimulation current

Timeline

Start date
2011-07-01
Primary completion
2012-09-01
Completion
2012-10-01
First posted
2011-10-12
Last updated
2013-01-24

Locations

3 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01450371. Inclusion in this directory is not an endorsement.